AYLA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 saus. 2023 @ 22:56):

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers...

Stats
Šios dienos apimtis	137 793
Vidutinė apimtis	50 544
Rinkos kapitalizacija	0.00
EPS	$-0.620 ( Q4 \| 2023-03-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0760 (15.09%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO -0.44%

ABIO 2.17%

ABOS -0.40%

ABSI -0.15%

ABUS 0.33%

ABVX -0.22%

ACAD 0.54%

ACER -17.95%

ACET 0.00%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP 0.33%

ADGI 0.87%

ADIL 1.57%

ADMA 0.19%

ADPT -0.96%

ADTX -1.27%

ADVM -0.55%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -1.89%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 3.34%

ALEC 0.44%

ALGS -0.25%

ALKS 0.34%

ALLK -0.85%

ALLO -1.74%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.51%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.14%

ANL 0.61%

ANNX -0.65%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.79%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.16%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR 0.00%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.75%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 2.17%

ATRA -2.10%

ATXI -1.66%

ATXS 0.45%

AUPH -0.36%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.56%

AVTX 4.15%

AVXL 0.00%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.40%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI 1.23%

BCRX -0.24%

BCTX -0.68%

BCTXW 0.00%

BCYC 0.00%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -0.61%

BMEA -0.20%

BMRN 0.19%

BNOX 10.76%

BNTC 2.46%

BNTX 0.14%

BOLD 0.49%

BOLT -0.50%

BPMC 0.28%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.90%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -1.41%

CADL -1.11%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.15%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.19%

CDXS -1.49%

CELC 1.03%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.41%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.84%

CGEN -1.02%

CGON 0.00%

CGTX 1.39%

CHMA -6.00%

CHRS -0.01%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.89%

CLGN 0.30%

CLLS -6.54%

CLNN 0.37%

CLNNW -41.25%

CLRB 0.64%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 1.82%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -1.73%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT 0.10%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU 0.00%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.16%

CRSP 0.28%

CRTX 2.63%

CRVO -1.89%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 3.65%

CTNM -2.94%

CTXR 1.43%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.13%

CYTO -3.23%

DARE 1.19%

DAWN 0.42%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.00%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 3.73%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 1.92%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.50%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.23%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI -0.20%

EXEL -0.30%

EYEG -0.43%

EYEN -0.33%

EYPT -0.22%

FATE 0.42%

FBIO 0.21%

FBIOP 1.09%

FBLG -1.17%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD -0.30%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.76%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.96%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -1.83%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.95%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 11.54%

GOVX 17.86%

GOVXW -24.72%

GPCR 0.94%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.75%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO 0.51%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.66%

HSTO 62.16%

HUMA -0.32%

HUMAW -5.97%

IBRX 0.34%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -0.81%

IMGN 0.02%

IMGO 0.00%

IMMP -1.47%

IMMX -0.49%

IMNM -1.06%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT -0.17%

INAB -0.02%

INBX -0.35%

INCY 0.18%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.23%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -6.11%

IONS -0.37%

IOVA -0.25%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -0.09%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX 0.17%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.57%

KRRO -0.63%

KRTX 0.03%

KRYS 0.24%

KTRA 9.27%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX -0.25%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.97%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.46%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.70%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -1.93%

LQDA -0.23%

LRMR 1.13%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL 3.12%

LYRA -1.26%

MACK 0.00%

MBIO 37.29%

MBRX -4.83%

MCRB -0.88%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.12%

MGNX -2.46%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.20%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.20%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.00%

MNMD 1.14%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.54%

MORF 1.36%

MREO 0.00%

MRKR -4.76%

MRNA -0.86%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS 3.25%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -0.85%

NKTX -1.23%

NLSP 159.41%

NLSPW 8.38%

NMRA 0.53%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.56%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL 0.43%

NVAX -1.14%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -3.21%

OCGN 3.61%

OCS -1.09%

OCUL -1.45%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 6.72%

ONCO 18.31%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -5.02%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX 0.10%

PDSB 0.19%

PEPG 0.70%

PGEN 0.63%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.56%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 1.03%

PRQR -5.29%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 17.86%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.75%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -0.28%

RCKT 0.19%

REGN 0.15%

RENB 0.00%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.26%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.54%

RLAY 0.21%

RLMD 0.00%

RLYB 0.00%

RNA -1.52%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.45%

ROIV 0.28%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.04%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC 0.36%

RVPH 0.00%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.75%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.91%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 1.55%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -1.73%

SMMT 0.63%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.63%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.52%

SWTX -1.41%

SYBX -0.63%

SYRS -2.63%

TALS -0.73%

TARA -1.17%

TARS 2.50%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.00%

TFFP -2.05%

TGTX 0.31%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.59%

TNXP 0.00%

TNYA 0.00%

TPST 0.34%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -6.34%

TSVT -0.49%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.29%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.29%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 1.14%

VRPX -11.90%

VRTX -0.06%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 6.96%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.97%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.30%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-10-18	Martell Bridget A	Buy	0
2023-10-18	Orbach Pini	Buy	0
2023-10-18	Golan Roy	Buy	0
2023-01-19	Amoon Growth Fund Limited Partnership	Sell	2 991 473	Common Stock
2023-01-19	Sidransky David	Sell	12 500	Stock Option (right to buy)

INSIDER POWER
-99.86
Last 84 transactions
Buy: 4 327 382 \| Sell: 8 482 924

Tūris Koreliacija

Ilgas: 0.26 (neutral)

Trumpas: -0.81 (strong negative)

Signal:(50.563) Neutral

Ayala Pharmaceuticals Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos
THAC	-0.849
SVFA	-0.839
NAAC	-0.834
AEAC	-0.823
TZPS	-0.822

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Ayala Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos

0.59
( weak )

0.51
( weak )

-0.45
( neutral )

-0.16
( neutral )

0.20
( neutral )

-0.73
( moderate negative )

Ayala Pharmaceuticals Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$692 000
Bruto pelnas:	$90 000.00 (13.01 %)
EPS:	$-2.46

FY	2022
Pajamos:	$692 000
Bruto pelnas:	$90 000.00 (13.01 %)
EPS:	$-2.46

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$-3.51M (0.00 %)
EPS:	$-4.69

FY	2020
Pajamos:	$3.71M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-3.06

Financial Reports:

No articles found.

Ayala Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ayala Pharmaceuticals Inc

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.